Immune responses of therapeutic lipid nanoparticles
Immune responses of therapeutic lipid nanoparticles
Nanoparticle-based drug delivery is an emerging technology for targeting therapeutics to the diseased site for enhanced therapy and reduced toxicity. A number of pharmaceutical products that involve nanotechnology have been approved for clinical use, and because of altered pharmacokinetics and biodistribution, their profiles of interaction with host cells and resulting toxicity are different from parent agents. This review focuses on the immune responses induced by therapeutic lipid nanoparticles. These immune responses can provoke toxicity, affect pharmacokinetics of the nanoparticles or induce therapeutic effect. This article begins with a general introduction on immune responses and innate and acquired immunity. Specific examples of therapeutic lipid nanoparticles inducing immune responses in each category are presented with detailed discussions on the mechanisms. Current guidelines for evaluating immune response of nanomedicines are summarized. Finally, perspectives and future directions are provided emphasizing mechanistic studies of immune reactions triggered by nanoparticles.
Immune response, Lipid nanoparticle, Nanomedicine
201-213
Chen, Weihsu Claire
ad0f0c85-758f-43dd-9584-389505ae0bf2
May, Jonathan P.
b54a262b-9f32-4435-8866-3b9c495294f3
Li, Shyh Dar
9a960896-36e7-4eb8-bd39-55580c60e36d
1 April 2013
Chen, Weihsu Claire
ad0f0c85-758f-43dd-9584-389505ae0bf2
May, Jonathan P.
b54a262b-9f32-4435-8866-3b9c495294f3
Li, Shyh Dar
9a960896-36e7-4eb8-bd39-55580c60e36d
Chen, Weihsu Claire, May, Jonathan P. and Li, Shyh Dar
(2013)
Immune responses of therapeutic lipid nanoparticles.
Nanotechnology Reviews, 2 (2), .
(doi:10.1515/ntrev-2012-0040).
Abstract
Nanoparticle-based drug delivery is an emerging technology for targeting therapeutics to the diseased site for enhanced therapy and reduced toxicity. A number of pharmaceutical products that involve nanotechnology have been approved for clinical use, and because of altered pharmacokinetics and biodistribution, their profiles of interaction with host cells and resulting toxicity are different from parent agents. This review focuses on the immune responses induced by therapeutic lipid nanoparticles. These immune responses can provoke toxicity, affect pharmacokinetics of the nanoparticles or induce therapeutic effect. This article begins with a general introduction on immune responses and innate and acquired immunity. Specific examples of therapeutic lipid nanoparticles inducing immune responses in each category are presented with detailed discussions on the mechanisms. Current guidelines for evaluating immune response of nanomedicines are summarized. Finally, perspectives and future directions are provided emphasizing mechanistic studies of immune reactions triggered by nanoparticles.
This record has no associated files available for download.
More information
Published date: 1 April 2013
Keywords:
Immune response, Lipid nanoparticle, Nanomedicine
Identifiers
Local EPrints ID: 455302
URI: http://eprints.soton.ac.uk/id/eprint/455302
ISSN: 2191-9089
PURE UUID: 9cbf9648-1a92-4557-bd70-e71b9e12e7a7
Catalogue record
Date deposited: 16 Mar 2022 18:04
Last modified: 18 Mar 2024 03:49
Export record
Altmetrics
Contributors
Author:
Weihsu Claire Chen
Author:
Shyh Dar Li
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics